Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA
Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDAs recent moves to end…
19,320$
-7,34%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers launches GLP-1 tracker in response to FDAs shortage decision
Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDAs recent moves to end…
Hims & Hers launches GLP-1 tracker in response to FDAs shortage decision
…
Hims & Hers Health plans to launch generic of Novo Nordisks Victoza
Liraglutide, used to treat Type 2 diabetes, belongs to the first generation of GLP-1 agonists.…
Hims & Hers Health Inc (HIMS-N) Quote
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today shared more data…
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
The healthcare company is on fire, and its still cheap by many measures.…
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
The healthcare company is on fire, and its still cheap by many measures.…
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
Shares of Hims & Hers Health (NYSE: HIMS) have been on fire over the past year, but theyre not expensive…
Up 298% in a Year, Is Hims & Hers Health Still a Buy? @themotleyfool #stocks $HIMS
The healthcare company is on fire, and its still cheap by many measures.…
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to…
WealthPlan Investment Management LLC Makes New $1.04 Million Investment in Hims & Hers Health, Inc. (NYSE:HIMS)
WealthPlan Investment Management LLC acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free…
Hims & Hers Health (HIMS) Turning Heads with Record Revenue Growth
Hims Hers Health ($HIMS) is turning heads, making substantial strides, and grabbing investors’ attention. Its strategy centered on the…
Hims & Hers Healths (NYSE:HIMS) Strong Earnings Are Of Good Quality
Hims & Hers Health, Inc. ( NYSE:HIMS ) just reported some strong earnings, and the market reacted accordingly with a...…
Hims & Hers Shares Jump 17%: Explosive Growth, Insider Confidence, and Big Money Moves
Wall Street piles in as insiders hold strong and institutional investors boost stakes in this telehealth powerhouse.…
Hims & Hers Health, up 20%, hits all-time high (HIMS:NYSE)
Hims & Hers Health stock soars 20% as TD Cowen raises price target…
Wachstumsaktie im Höhenflug: Hims profitiert von politischem Rückenwind!
Meine favorisierte Wachstumsaktie legt heute weitere 20 % zu, wodurch Leser des GROWTH-Magazins ihren Einsatz nun vervierfacht haben. Der aktuelle…
Hims & Hers Shares Jump 17%: Explosive Growth, Insider Confidence, and Big Money Moves
Wall Street piles in as insiders hold strong and institutional investors boost stakes in this telehealth powerhouse.…
Hims & Hers Health (NYSE:HIMS) Sets New 52-Week High Following Analyst Upgrade
Hims & Hers Health (NYSE:HIMS) Hits New 1-Year High on Analyst Upgrade…
Hims & Hers Health Inc (HIMS) Shares Up 23.24% on Nov 11
Shares of Hims & Hers Health Inc (HIMS) surged 23.24% in mid-day trading on Nov 11. The stock reached an…
Robeco Institutional Asset Management B.V. Buys New Shares in Hims & Hers Health, Inc. (NYSE:HIMS)
Robeco Institutional Asset Management B.V. bought a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…
Hims & Hers: Undeservedly Undervalued
…
Hims & Hers: A High-Growth Gem On The Verge Of Big Upside (NYSE:HIMS)
Hims & Hers is revolutionizing telehealth and wellness for millennials and Gen Z with rapid revenue growth and positive net…
Hims & Hers: A High-Growth Gem On The Verge Of Big Upside
…
Hims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, TD Cowen Analyst Says
TD Cowen upped their price target on Hims & Hers Health from $25.00 to $28.00 and gave the company a…
Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy?
Hims & Hers Health, Inc. (HIMS) could be a solid choice for investors given the companys remarkably improving earnings outlook.…
Hims & Hers - Telemedizinspezialist profitiert massiv von dynamischem Neukundenwachstum bei Adipositas-Nachahmerpräparaten!
Geschäftstreiber: Hims &Hers (HIMS) gehört zu den führenden US-Anbietern im Bereich Telemedizin, wobei man Patienten bei sensiblen gesundheitlichen Themenbereichen wie…
Hims & Hers price target raised to $28 from $25 at TD Cowen
TD Cowen analyst Jonna Kim raised the firm’s price target on Hims Hers to $28 from $25 and keeps…
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
Hims & Hers strong performance involves much more than just GLP-1 drugs.…
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy? @themotleyfool #stocks $HIMS
Hims & Hers strong performance involves much more than just GLP-1 drugs.…
Hims & Hers health chief medical officer Carroll sells $331,093 in stock By Investing.com
Hims & Hers health chief medical officer Carroll sells $331,093 in stock…
Hims & Hers CEO Andrew Dudum sells $6.9 million in stock By Investing.com
Hims & Hers CEO Andrew Dudum sells $6.9 million in stock…
Hims & Hers chief commercial officer sells $45,188 in stock By Investing.com
Hims & Hers chief commercial officer sells $45,188 in stock…
Hims & Hers Health Inc (HIMS) Stock Price Up 2.82% on Nov 7
Shares of Hims & Hers Health Inc (HIMS) surged 2.82% in mid-day trading on Nov 7. The stock reached an…
Seaport Res Ptn Has Positive Outlook of HIMS FY2024 Earnings
Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn upped their FY2024…
Stock Traders Purchase High Volume of Hims & Hers Health Call Options (NYSE:HIMS)
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) saw unusually large options trading activity on Wednesday. Stock investors…
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
According to analysts, even after a 6% rally on the morning of the earnings announcement, Hims & Hers stock might…
Hims & Hers: Why This Healthcare Stocks Growth Makes It a Buy
Most investors would look at an earnings announcement as a past event, connecting the current price action in the stock…
Hims & Hers Health Third Quarter 2024 Earnings: Beats Expectations
Hims & Hers Health ( NYSE:HIMS ) Third Quarter 2024 Results Key Financial Results Revenue: US$401.6m (up 77% from 3Q...…
Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Hims & Hers Health, Inc. ( NYSE:HIMS ) investors will be delighted, with the company turning in some strong numbers...…
Leerink Partnrs Has Bullish Estimate for HIMS Q4 Earnings
Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Analysts at Leerink Partnrs upped their Q4 2024 earnings…
Q4 EPS Estimate for Hims & Hers Health Boosted by Analyst
Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn upped their Q4…
Hims & Hers stock rallies amidst increased revenue, GLP-1 generic
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of…
Hims & Hers Health (NYSE:HIMS) Announces Quarterly Earnings Results, Beats Expectations By $0.26 EPS
Hims & Hers Health (NYSE:HIMS - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.32…
Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24 By Investing.com
Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24…
Whats Going On With Hims & Hers Health Stock Tuesday? - Hims & Hers Health (NYSE:HIMS)
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and…
Hims & Hers Health: Another Blowout Quarter Ignored (NYSE:HIMS)
Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the market. Learn more HIMS…
Hims & Hers will start selling a generic weight loss drug
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of…
Hims & Hers will start selling a generic weight loss drug
The telehealth company will start offering a generic version of liraglutide in 2025 as consumers continue to struggle to secure…
Hims & Hers Health (NYSE:HIMS) Shares Gap Up After Better-Than-Expected Earnings
Hims & Hers Health (NYSE:HIMS) Shares Gap Up on Strong Earnings…